INSP · Transaction Apr 10, 2023 · Filed May 19, 2023 · $1,001 to $15,000
Inspire Medical Systems Inc
Veridion Score
BETAMEDIUM CONF · 5/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is INSP moving today?
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
INSP overview
Related filings and maps
Congress activity in INSP
INSP contract awards, year to date.
Public federal awards linked to this ticker.
INSP lobbying filings, year to date.
Registered lobbying filings matched to Inspire Medical Systems Inc.